Schadendorf D - Search Results

1

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R. Garbe C, et al. Among authors: schadendorf d. Melanoma Res. 2008 Feb;18(1):61-7. doi: 10.1097/CMR.0b013e3282f0c893. Melanoma Res. 2008. PMID: 18227710

2

In vitro sensitivity of human melanoma cells to chemotherapeutic agents and interferons.

Schadendorf D, Jurgovsky K, Worm M, Czarnetzki BM. Schadendorf D, et al. Melanoma Res. 1994 Aug;4(4):243-9. doi: 10.1097/00008390-199408000-00006. Melanoma Res. 1994. PMID: 7524835

3

Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype.

Worm M, Schadendorf D, Czarnetzki BM. Worm M, et al. Among authors: schadendorf d. Melanoma Res. 1993 Feb;3(1):29-33. doi: 10.1097/00008390-199304000-00005. Melanoma Res. 1993. PMID: 7682461

4

The polymerase chain reaction. Method and applications in dermatopathology.

Volkenandt M, Burmer GC, Schadendorf D, Koch OM, Wienecke R, Degitz K. Volkenandt M, et al. Among authors: schadendorf d. Am J Dermatopathol. 1993 Apr;15(2):118-26. doi: 10.1097/00000372-199304000-00004. Am J Dermatopathol. 1993. PMID: 8494111 Review.

5

Expression of CD44 splice variants in human skin and epidermal tumours.

Seiter S, Tilgen W, Herrmann K, Schadendorf D, Patzelt E, Möller P, Zöller M. Seiter S, et al. Among authors: schadendorf d. Virchows Arch. 1996 Jun;428(3):141-9. doi: 10.1007/BF00200656. Virchows Arch. 1996. PMID: 8688968

6

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

Keilholz U, Goey SH, Punt CJ, Proebstle TM, Salzmann R, Scheibenbogen C, Schadendorf D, Liénard D, Enk A, Dummer R, Hantich B, Geueke AM, Eggermont AM. Keilholz U, et al. Among authors: schadendorf d. J Clin Oncol. 1997 Jul;15(7):2579-88. doi: 10.1200/JCO.1997.15.7.2579. J Clin Oncol. 1997. PMID: 9215828 Free article. Clinical Trial.

7

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Nestle FO, et al. Among authors: schadendorf d. Nat Med. 1998 Mar;4(3):328-32. doi: 10.1038/nm0398-328. Nat Med. 1998. PMID: 9500607 Clinical Trial.

8

[Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].

Hauschild A, Dummer R, Garbe C, Kaufmann R, Schadendorf D, Soyer HP, Stadler R, Tilgen W. Hauschild A, et al. Among authors: schadendorf d. Hautarzt. 1998 Mar;49(3):167-9. doi: 10.1007/s001050050722. Hautarzt. 1998. PMID: 9565782 German. No abstract available.

9

Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.

Mohr P, Makki A, Breitbart E, Schadendorf D. Mohr P, et al. Among authors: schadendorf d. Melanoma Res. 1998 Apr;8(2):166-9. doi: 10.1097/00008390-199804000-00011. Melanoma Res. 1998. PMID: 9610871 Clinical Trial.

10

CD44 variant isoform expression in a variety of skin-associated autoimmune diseases.

Seiter S, Schadendorf D, Tilgen W, Zöller M. Seiter S, et al. Among authors: schadendorf d. Clin Immunol Immunopathol. 1998 Oct;89(1):79-93. doi: 10.1006/clin.1998.4565. Clin Immunol Immunopathol. 1998. PMID: 9756727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,116 results

Search Page

Filters